LOSARTAN POTASSIUM

Post-LOE

losartan potassium

ANDAORALTABLET
Approved
Sep 2025
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
5

Clinical Trials (5)

NCT00856271Phase 3Completed

Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension

Started Aug 2004
287 enrolled
Essential Hypertension
NCT01149473Phase 1Completed

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions

Started Mar 2004
80 enrolled
Healthy
NCT00185094Phase 4Completed

A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin

Started Feb 2004
60 enrolled
HypertensionInsulin ResistanceMetabolic Syndrome
NCT01149486Phase 1Completed

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions

Started Jan 2004
20 enrolled
Healthy
NCT00882440Phase 3Completed

A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)

Started Dec 1990
576 enrolled
Hypertension